More recent data by Haanstraet al. showing the reduction of both CNS inflammation and demyelination in human EAE in rhesus macaques following the administration of FR104 CD28 blocking Ab31 strongly support a crucial role for CD28 in regulating the expansion and inflammatory function of autoreactive T cells in MS. This evidence concerns the gene CD28 and myeloid sarcoma.